Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aemetis (AMTX) Cash & Equivalents (2016 - 2025)

Aemetis (AMTX) has 15 years of Cash & Equivalents data on record, last reported at $5.6 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 1786.49% year-over-year to $5.6 million; the TTM value through Sep 2025 reached $5.6 million, up 1786.49%, while the annual FY2024 figure was $898000.0, 66.33% down from the prior year.
  • Cash & Equivalents reached $5.6 million in Q3 2025 per AMTX's latest filing, up from $1.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $15.8 million in Q1 2021 and bottomed at $234000.0 in Q2 2024.
  • Average Cash & Equivalents over 5 years is $4.0 million, with a median of $3.6 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 7987.34% in 2021, then plummeted 96.07% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $7.8 million in 2021, then plummeted by 44.36% to $4.3 million in 2022, then tumbled by 38.16% to $2.7 million in 2023, then plummeted by 66.33% to $898000.0 in 2024, then soared by 521.83% to $5.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $5.6 million in Q3 2025, $1.6 million in Q2 2025, and $499000.0 in Q1 2025.